title: Serotonin as a research platform for new drug discovery.
authors.affiliation: Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. lphebus@lilly.com
authors.forename: L A
authors.initials: LA
authors.lastname: Phebus
authors.forename: J M
authors.initials: JM
authors.lastname: Schaus
mesh_terms: D000818:Animals; D015195:Drug Design; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology; D009422:Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D018377:Neurotransmitter Agents; D011985:Receptors, Serotonin / Q000145:classification / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D018490:Serotonin Agents / Q000627:therapeutic use
chemical_list: D018377:Neurotransmitter Agents; D011985:Receptors, Serotonin; D018490:Serotonin Agents; D012701:Serotonin